# Continuing vs Intermittent Trabectedin in Patients With Advanced Soft Tissue Sarcoma

> **NCT01303094** · PHASE2 · COMPLETED · sponsor: **Centre Oscar Lambret** · enrollment: 53 (actual)

## Conditions studied

- Soft Tissue Sarcoma
- Uterine Sarcoma

## Interventions

- **DRUG:** Trabectedin
- **OTHER:** Drug: holiday

## Key facts

- **NCT ID:** NCT01303094
- **Lead sponsor:** Centre Oscar Lambret
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02
- **Primary completion:** 2018-05-16
- **Final completion:** 2018-08-09
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2026-03-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01303094

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01303094, "Continuing vs Intermittent Trabectedin in Patients With Advanced Soft Tissue Sarcoma". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT01303094. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*